PFS: progression-free survival; OS: overall survival; ORR: objective response rate; BRCA: breast cancer-associated; ATM: ataxia-telangiectasia mutated; PALB2: partner and localizer of BRCA2; HRD: homologous recombination deficiency. This evidence concerns the gene BRCA2 and breast carcinoma.